During the past decade, Comprensorio sanitario di Bolzano conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Comprensorio sanitario di Bolzano" #1 sponsor was "Fondazione Italiana Linfomi ONLUS" with 3 trials, followed by "Bolton Medical" with 1 trials sponsored, "International Extranodal Lymphoma Study Group (IELSG)" with 1 trials sponsored, "Oncologia Medica dell'Ospedale Fatebenefratelli" with 1 trials sponsored and "Vascutek Ltd." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Comprensorio sanitario di Bolzano" #1 collaborator was "Bolton Medical" with 1 trials as a collaborator, "Bolton Medical Espana SLU" with 1 trials as a collaborator and "Mario Negri Institute for Pharmacological Research" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Comprensorio sanitario di Bolzano" are "Abdominal Aortic Aneurysm" (1 trials), "Adverse Drug Event" (1 trials), "Aortic Aneurysm, Abdominal" (1 trials), "Diffuse Large B-cell Lymphoma" (1 trials) and "Drug Toxicity" (1 trials). Many other conditions were trialed in "Comprensorio sanitario di Bolzano" in a lesser frequency.

Most popular intervention types in "Comprensorio sanitario di Bolzano" are "Drug" (4 trials), "Device" (2 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "3D-Conformal Radiotherapy (3D-CRT)" (1 trials), "Abdominal" (1 trials), "Bendamustine+Rituximab" (1 trials), "Custom Device" (1 trials) and "ERIBULIN MESYLATE" (1 trials). Other intervention names were less common.

The vast majority of trials in "Comprensorio sanitario di Bolzano" are 6 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Comprensorio sanitario di Bolzano". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Comprensorio sanitario di Bolzano, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Comprensorio sanitario di Bolzano, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".